Zenas BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 77.83K shares, a 70.83% decline year-over-year.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 25.77K shares, a 9.51% decline year-over-year.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 82.00K shares.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 266.81K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 77.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | |
| 2026-03-31 | 25.77K shares 10-Q · filed 2026-05-13 | |
| 2025-09-30 | 82.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2025-06-30 | 266.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | |
| 2025-03-31 | 28.48K shares 10-Q · filed 2025-05-15 |